PRESS RELEASE published on 06/25/2025 at 14:43, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Aviva plc The Vanguard Group, Inc. discloses 5.21% stake in Aviva plc through form 8.3. Position disclosed on 24 June 2025 Financial Position The Vanguard Group, Inc. Form 8.3 Stake Disclosure Aviva Plc
PRESS RELEASE published on 06/25/2025 at 14:42, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses a 1.43% interest in Alphawave IP Group plc through Form 8.3. Also making disclosures regarding Qualcomm Incorporated Form 8.3 The Vanguard Group Disclosures Alphawave IP Group Plc Qualcomm Incorporated
PRESS RELEASE published on 06/25/2025 at 14:41, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses 4.50% stake in Unite Group plc. Purchase of 1,325 securities at 8.52 GBP per unit. Form 8.3 submitted under Takeover Code Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Unite Group Plc
BRIEF published on 06/24/2025 at 15:15, 1 year 3 months ago The Vanguard Group Discloses Position in Qualcomm Securities Form 8.3 Takeover Code Vanguard Qualcomm
BRIEF published on 06/24/2025 at 15:15, 1 year 3 months ago Le groupe Vanguard révèle sa position dans Qualcomm Titres Code De Prise De Contrôle Formulaire 8.3 Avant-garde Qualcomm
BRIEF published on 06/24/2025 at 15:15, 1 year 3 months ago Vanguard Group's Disclosure on American Axle & Manufacturing Holdings Securities Form 8.3 Disclosure Vanguard Group American Axle
BRIEF published on 06/24/2025 at 15:15, 1 year 3 months ago Divulgation du groupe Vanguard concernant American Axle & Manufacturing Holdings Titres Groupe Vanguard Divulgation Formulaire 8.3 Essieu Américain
BRIEF published on 06/24/2025 at 15:14, 1 year 3 months ago The Vanguard Group Discloses Stake in Mural Oncology Irish Takeover Panel Vanguard Group Financial Regulation Shareholding Disclosure Mural Oncology
BRIEF published on 06/24/2025 at 15:14, 1 year 3 months ago Le groupe Vanguard révèle sa participation dans Mural Oncology Réglementation Financière Groupe Vanguard Divulgation Des Actions Commission Irlandaise Des Acquisitions Oncologie Murale
BRIEF published on 06/24/2025 at 15:12, 1 year 3 months ago The Vanguard Group Discloses Interest in Aviva plc Takeover Code Vanguard Group Form 8.3 Disclosure Securities Interest Aviva Plc
Published on 10/22/2026 at 22:30, 1 hour 6 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 7 hours 36 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 9 hours 6 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/22/2026 at 14:00, 9 hours 36 minutes ago Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors
Published on 10/22/2026 at 22:10, 1 hour 26 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 3 hours 36 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 3 hours 51 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 4 hours 51 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:30, 5 hours 6 minutes ago lePERMISLIBRE annonce l’organisation d’une visioconférence destinée aux actionnaires et investisseurs
Published on 10/22/2026 at 18:00, 5 hours 36 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 5 hours 36 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 5 hours 36 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 5 hours 36 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 5 hours 36 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
